News ImpediMed Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:46 30/04/2024 BST			5-day change	1st Jan Change
0.084 ^AUD	-5.62%		-6.67%	-42.07%

05:03am	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
03:00am	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	04:03am	MT
Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024	02:00am
Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	04-17	MT
Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	04-17	MT
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	04-11	CI
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	03-17	CI
Impedimed Names Independent Non-Executive Chair	02-27	MT
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	02-27	MT
Transcript : ImpediMed Limited, H1 2024 Earnings Call, Feb 27, 2024	02-27
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26	CI
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	02-14	MT
Transcript : ImpediMed Limited, Q2 2024 Earnings Call, Feb 01, 2024	02-01
Transcript : ImpediMed Limited - Shareholder/Analyst Call	11-30
ImpediMed CEO, CFO Step Down; Shares Fall 11%	11-20	MT
ImpediMed Limited Announces CEO Changes	11-19	CI
ImpediMed Limited Announces CFO Changes	11-19	CI
ImpediMed Limited Announces Management Changes	11-19	CI
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	11-03	MT
Morgans rates IPD as Add	10-31	AQ
Transcript : ImpediMed Limited, Q1 2024 Earnings Call, Oct 31, 2023	30/10/23

No results for this search